Triglav Investments D.O.O. boosted its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 211.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,700 shares of the conglomerate’s stock after purchasing an additional 12,700 shares during the period. Triglav Investments D.O.O.’s holdings in Danaher were worth $4,281,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Sivia Capital Partners LLC lifted its stake in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares during the last quarter. First Trust Advisors LP lifted its stake in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC lifted its stake in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after acquiring an additional 886 shares during the last quarter. Ieq Capital LLC increased its holdings in Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC increased its holdings in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the period. 79.05% of the stock is currently owned by institutional investors.
Danaher Price Performance
Shares of NYSE DHR opened at $182.73 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market cap of $129.33 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 2.41 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm’s 50-day simple moving average is $182.11 and its 200 day simple moving average is $207.48.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Analyst Ratings Changes
A number of analysts have weighed in on DHR shares. Rothschild & Co Redburn set a $205.00 price target on Danaher in a report on Friday, April 17th. The Goldman Sachs Group decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Evercore increased their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Finally, Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $238.24.
Check Out Our Latest Analysis on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- MarketBeat Week in Review – 05/25 – 05/29
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
